Дополнительные материалы

1. Ramer-Quinn D, Baker R, Sanders V: Activated T helper 1 and T helper 2 cells differentially express the b2- adrenergic receptor. J Immunol 159: 4857-4867, 1997
2. Maestroni G: Sympathetic nervous system influence on the innate immune response. Ann NY Acad Sci 1069: 195-207, 2006
3. Kin N, Sanders V: It takes nerve to tell T and B cells what to do. J Leukoc Biol 79: 1093-1104, 2006
4. Perkins G, McAuley D, Richter A, et al: Bench-to-bed­ side review: j32-agonists and the acute respiratory distress syndrome. Crit Care 8: 25-32, 2004
5. Maestroni G: Sympathetic nervous system influence on the innate immune response. Ann NY Acad Sci 1069: 195-207, 2006
6. Sanders V: Interdisciplinary research: noradrenergic reg­ ulation of adaptive immunity. Brain Behavior Immunity 20: 1-8, 2006
7. Sanders V, Straub R: Norepinephrine, the B-adrenergic receptor, and immunity. Brain Behavior Immunity 16: 290-332, 2002
8. Moynihan J, Kruszewska B, Madden K, et al: Sympa­ thetic nervous system regulation of immunity. J Neuro - immunol 147: 87-90, 2004

Список литературы

1. Steinman L: Elaborate interactions between the immune and nervous systems. Nat Immun 5: 575-581, 2004
2. Elenkov I, Wilder R, Chrousos G, et al: The sympathetic nerve: an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52: 595-638, 2000
3. Felten D, Felten S, Carlson S, et al: Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135: 755s-765s, 1985
4. Bellinger D, Lorton D, Felten S, et al: Innervation of lymphoidorgans and implication in development, aging, and autoimmunity. Int J Im munopharmacol 14: 329-344, 1994
5. Felten D, Felten S, Bellinger D, et al: Noradrenergic sympathetic neural interactions with immune system: structure and function. Im­ munol Rev 100: 225-260, 1987
6. Felten D, Felten S: Sympathetic noradrenergic innervation of immune organs. Brain Behav Immun 4: 293-300, 1998
7. Reilly F, McCuskey P, Miller M, et al: Innervation of the periarteriolar lymphatic sheath of the spleen. Tissue Cell 11: 121-126, 1979
8. Berkenbosch F, van Oers J, del Ray A, et al: Corticotropin-releasing factor producing neurons in the rat activated by interleukin-1. Science 238: 524-526, 1987
9. Sapolsky R, River C, Yamamoto G, et al: Interleukin-1 stimulates the secretion of hypothalamic corticotrophin-releasing factor. Science 238: 522-524, 1987
10. unn A: Systemic interleukin-1 administration stimulates hypotha lamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci 43: 429-435, 1988
11. Elenkov I, Kovacs K, Duda E, et al: Presynaptic inhibitory effect of TNF-a on the release of noradrenaline in isolated median eminence. J Neuroimmunol 41: 117-120, 1992
12. Kovacs K, Elenkov I: Differential dependence of ACTH secretion induced by various cytokines on the integrity of the paraventricular nucleus. J Neuroendocrinol 7: 15-23, 1995
13. Katafuchi T, Hori T, Take S: Central administration of interferon- alpha enhances rat sympathetic nerve activity to the spleen. Neurosci Lett 125: 37-40, 1991
14. Paul W: Fundamental Immunology. Lippincott Williams & Wilkins, Philadelphia, PA. (ed 5) 2003
15. Sanders V, Baker R, Ramer-Quinn S, et al: Differential expression of the b2-adrenergic receptor by Thl and Th2 clones. Implications for cytokine production and B cell help. J Immunol 158: 4200-4210, 1997
16. Feldman R, Hunningshake G, McArdle W: Beta-adrenergic receptor mediated suppression of interleukin 2 receptors in human lympho­ cytes. J Immunol 139: 3355-3359, 1987
17. Bartik M, Brooks W, Roszman T: Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation. Cell Immunol 148: 408-421, 1993
18. Bauman G, Bartik M, Brooks W, et al: Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the pros taglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. Cell Immunol 158: 182-194, 1994
19. Minakuchi R, Wacholtz M, Davis L, et al: Delineation of the mecha­ nisms of inhibition of T cell activation by PGE2. J Immunol 145: 2616- 2625, 1990
20. Swanson M, Lee W, Sanders V: IFN-y production by Thl cells generated from naive CD4 + T cells exposed to norepinephrine. J Im­ munol 166: 232-240, 2001
21. Kohm A, Sanders V: Suppression of antigen-specific Th2 cell-depen­ dent IgM and IgGl production following norepinephrine depletion in vitro. J Immunol 162: 5299-5308, 1999
22. Kasprowicz D, Kohm A, Berton M, et al: Stimulation of the B cell receptor, CD 86 (B7-2), and the j32-adrenergic receptor intrinsically modulates the level of IgGl and IgE produced per B cell. J Immunol 165: 680-690, 2000
23. Podojil J, Sanders V: Selective regulation of mature IgGl transcription by CD86 and b2 -adrenergic receptor stimulation. J Immunol 170: 5143-5151, 2003
24. Podojil J, Kin N, Sanders V: CD86 and b2 -adrenergic receptor sig­ naling pathways, respectively increase Oct-1 and OCA-B expression and binding to the 3'-IgH enhancer in B cells. J Biol Chem 279: 23394- 23404, 2004
25. Roper R, Graf B, Phipps R: Prostaglandin E2 and cAMP promote B lymphocyte class switching to IgGl. Immunol Lett 84: 191-198, 2002
26. Galizzi J, Cabrillat H, Rousset F, et al: IFN-7 and prostaglandin E2 inhibit IL-4 induced expression of Fc epsilon R2/CD23 on B lympho­cytes through different mechanism without altering binding of IL-4 to its receptor. J Immunol 141: 1982-1988, 1988
27. Kohm A, Mozaffarian A, Sanders V: B cell receptor and the b2 - adrenergic receptor-induced regulation of B7-2 (CD86) expression in B cells. J Immunol 168: 6314-6322, 2002
28. Podojil J, Sanders V: CD86 and /32-adrenergic receptor stimulation regulates B-cell activity cooperatively. Trends Immunol 26: 180-185, 2005
29. Bolton P, Lefevre P, McDonald D: Salmeterol reduces early and late-phase plasma leakage and leukocyte adhesion in rat airways. Am J Respir Crit Care Med 155: 1428-1435, 1997
30. Panina-Bordignon P, Mazzeo D, Lucia P, et al: /32-agonists prevent Thl development by selective inhibition of interleukin 12. J Clin Invest 100: 1513-1519, 1997
31. Wahle M, Kolker S, Krause A, et al: Impaired catecholaminergic signaling of B lymphocytes in patients with chronic rheumatic dis­ eases. Ann Rheum Dis 60: 505-510, 2001
32. Wahle M, Pierer M, Krause A, et al: Decreased catecholamine-induced cell death in B lymphocytes from patients with rheumatoid arthritis. Ann NY Acad Sci 966: 425-428, 2002
33. Pugin J, Verghese G, Widmer M, et al: The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 27: 304-312, 1999
34. Barnett C, Moore E, Patrick D, et al: /3-adrenergic stimulation down regulates neutrophil priming for superoxide generation, but not elas tase release. J Surg Res 70: 166-170, 1997
35. Harvath C, Robbins J, Russell A, et al: cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic re­sponsiveness. J Immunol 146: 224-232, 1991
36. Silvestri M, Oddera S, Cantero S, et al: b2 agonist induced inhibition of neutrophil chemotaxis is not associated with modification of LFA-1 and MAC-1 expression or with impairment of PMN antibacterial activity. Resp Med 93: 416-423, 1999
37. Maris N, van der Sluijs K, Florquin S, et al: Salmeterol, a b2 -receptor agonist, attenuates lippolysaccharide-induced lung inflammation in mice. Am J Physiol Lung Cell Mol Physiol 286: L1122-L1128, 2004
38. Lee E, Smith J, Robertson P, et al: Salmeterol and inhibitors of PDE4 induced apoptosis in neutrophils from asthmatics: b -adrenergic receptor mediated salmeterol activity and additive effects with PDE4 inhibitors, [abstract] Am J Resp Cell Mol Biol 159: A329, 1999
39. Bowden J, Sulakvelidze I, McDonald: Inhibition of neutrophil and eosinophil adhesion to venules of rat trachea by b2 -adrenergic agonist formoterol. J Appl Physiol 77: 397-405, 1994
40. Zetterlund A, Linden M, Larsson K: Effects of beta2-agonist and bedesonide on interleukin-lbeta and leukotriene B4 secretion: studies of human monocytes and alveolar macrophages. J Asthma 35: 565-573, 1998
41. Severn A, Rapson N, Hunter C, et al: Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immu­ nol 148: 3441-3445, 1992
42. Gu Y, Seidel A: Influence of salbutamol and isoproterenol on the production of TNF and reactive oxygen species by bovine alveolar macrophages and calcitriol differentiated HL-60 cells. Immunopharmacol Immunotoxicol 18: 115-128, 1996
43. Monastra G, Secchi E: Beta-adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release. Immunol Lett 38: 127-130, 1993
44. Sekut L, Champion B, Page K, et al: Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clin Exp Immu­ nol 99: 461-466, 1995
45. van der Poll T, Jansen J, Endert E, et al: Noradrenaline inhibit lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production inhuman whole blood. Infect Immun 62: 2046-2050, 1994
46. van der Poll T, Coyle S, Barbosa K, et al: Epinephrine inhibits tumor necrosis factor-a and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 97: 713-719, 1996